Dr. Abdelmalek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street, SW
Rochester, MN 55905
Education & Training
University of Missouri Kansas City School of MedicineClass of 1992
Certifications & Licensure
AZ State Medical License 1996 - Present
MN State Medical License 2022 - 2025
NC State Medical License 2006 - 2022
FL State Medical License 1998 - 2011- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis Start of enrollment: 2023 Jan 23
Roles: Contact
- Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Start of enrollment: 2021 May 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 116 citationsNonalcoholic Fatty Liver Disease as a Complication of Insulin ResistanceManal F. Abdelmalek, Anna Mae Diehl
The Medical Clinics of North America. 2007-11-01 - 228 citationsClinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, Kim Pfotenhauer, Vincent Wai-Sun Wong
Gastroenterology. 2021-11-01 - 417 citationsA multisociety Delphi consensus statement on new fatty liver disease nomenclature.Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal
Hepatology. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
